Growth Metrics

Crescent Biopharma (CBIO) Net Income towards Common Stockholders (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Crescent Biopharma 569.36 Mn 380.20 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 74.24%
Dec 31, 2025 -267.36%
Sep 30, 2025 -12.93%
Jun 30, 2025 -43.85%
Mar 31, 2025 15.22%
Dec 31, 2024 -579.10%
Sep 30, 2024 73.94%
Jun 30, 2024 5.97%
Mar 31, 2024 -18.26%
Dec 31, 2023 1.35%
Sep 30, 2023 -11.43%
Jun 30, 2023 20.28%
Mar 31, 2023 -1.12%
Dec 31, 2022 -20.18%
Sep 30, 2022 35.75%
Jun 30, 2022 9.46%
Mar 31, 2022 15.89%
Dec 31, 2021 -0.52%
Sep 30, 2021 -20.37%
Jun 30, 2021 -0.88%
Mar 31, 2021 8.28%
Dec 31, 2020 -13.41%
Sep 30, 2020 2.53%
Jun 30, 2020 -83.74%
Mar 31, 2020 47.97%
Dec 31, 2019 -11.13%
Sep 30, 2019 16.29%
Jun 30, 2019 -12.40%
Mar 31, 2019 -1.27%
Dec 31, 2018 -20.14%
Sep 30, 2018 1.78%
Jun 30, 2018 -4.49%
Mar 31, 2018 -18.28%
Dec 31, 2017 -16.55%
Sep 30, 2017 0.75%
Jun 30, 2017 -3.43%
Mar 31, 2017 4.64%
Dec 31, 2016 -5.98%
Sep 30, 2016 2.55%
Jun 30, 2016 -6.84%
Mar 31, 2016 14.77%
Dec 31, 2015 -23.99%
Sep 30, 2015 -168.99%
Jun 30, 2015 246.07%
Mar 31, 2015 3.86%
Dec 31, 2014 -11.80%
Sep 30, 2014 -182.81%
Jun 30, 2014 256.64%
Mar 31, 2014 -31.92%
Dec 31, 2013 -4.50%
Sep 30, 2013 -5.83%
Jun 30, 2013 -860.75%